Effect of Erythropoietin and Stem Cells on Traumatic Brain Injury.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Neurosurgery

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.wneu.2016.01.040PMID 26850972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.

  2015cited by this paper
• Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury

  2015cited by this paper
• Survival outcomes in elderly patients with glioblastoma.

  2015cited by this paper
• Neuro-oncology: The many challenges of treating elderly glioblastoma patients

  2015cited by this paper
• The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.

  2015cited by this paper
• Effect of the treatment of focal brain ablation in rat with bone marrow mesenchymal stromal cells on sensorimotor recovery and cytokine production.

  2015cited by this paper
• Glioblastoma multiforme in the very elderly

  2015cited by this paper
• The risk of adverse outcomes in hospitalized older patients in relation to a frailty index based on a comprehensive geriatric assessment.

  2014cited by this paper
• Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis.

  2014cited by this paper
• Erythropoietin Improved Cognitive Function and Decreased Hippocampal Caspase Activity in Rat Pups after Traumatic Brain Injury

  2014cited by this paper
• Bone marrow mesenchymal stem cell transplantation in acute brain trauma

  2013cited by this paper
• Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat.

  2013cited by this paper
• Optimal management of elderly patients with glioblastoma.

  2013cited by this paper
• Frailty in elderly people.

  2013cited by this paper
• Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective.

  2013cited by this paper
• Neural Stem-Like Cells Derived from Human Amnion Tissue are Effective in Treating Traumatic Brain Injury in Rat

  2013cited by this paper
• Frailty as a predictor of morbidity and mortality in inpatient head and neck surgery.

  2013cited by this paper
• Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury

  2013cited by this paper
• Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect

  2013cited by this paper
• Erythropoietin neuroprotection with traumatic brain injury.

  2013cited by this paper
• Simplified frailty index to predict adverse outcomes and mortality in vascular surgery patients.

  2013cited by this paper
• Simple frailty score predicts postoperative complications across surgical specialties.

  2013cited by this paper
• Erythropoietin and cytoprotective cytokines in experimental traumatic brain injury.

  2013cited by this paper
• A modified frailty index to assess morbidity and mortality after lobectomy.

  2013cited by this paper
• Transplantation of mesenchymal stem cells to the brain by topical application in an experimental traumatic brain injury model.

  2013cited by this paper
• Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.

  2013cited by this paper
• Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model

  2013cited by this paper
• Aging population and future burden of pneumococcal pneumonia in the United States.

  2012cited by this paper
• Functional recovery after injury of motor cortex in rats: effects of rehabilitation and stem cell transplantation in a traumatic brain injury model of cortical resection

  2012cited by this paper
• SDF-1α induces angiogenesis after traumatic brain injury.

  2012cited by this paper
• Neuroprotective Effect of Mesenchymal and Neural Stem and Progenitor Cells on Sensorimotor Recovery after Brain Injury

  2012cited by this paper
• Lithium Ameliorates Neurodegeneration, Suppresses Neuroinflammation, and Improves Behavioral Performance in a Mouse Model of Traumatic Brain Injury

  2012cited by this paper
• Transplantation of neural stem cells enhances expression of synaptic protein and promotes functional recovery in a rat model of traumatic brain injury.

  2011cited by this paper
• Erythropoietin prevents secondary brain injury induced by cortical lesion in mice: possible involvement of Nrf2 signaling pathway.

  2011cited by this paper
• Progress and prospects: stem cells and neurological diseases

  2011cited by this paper
• The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.

  2011cited by this paper
• Treatment of Glioblastoma in “Elderly” Patients

  2011cited by this paper
• Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007

  2011cited by this paper
• Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma*

  2011cited by this paper
• The frailty syndrome.

  2011cited by this paper
• Mesenchymal Stem Cell Therapy Modulates the Inflammatory Response in Experimental Traumatic Brain Injury

  2011cited by this paper
• Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury.

  2011cited by this paper
• Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status

  2010cited by this paper
• Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

  2010cited by this paper
• Frailty as a predictor of surgical outcomes in older patients.

  2010cited by this paper
• Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities

  2010cited by this paper
• Angiogenesis in breast cancers without lymph node metastasis

  2010cited by this paper
• Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?

  2010cited by this paper
• Bevacizumab and chemotherapy for recurrent glioblastoma

  2009cited by this paper
• Glioblastoma in the elderly

  2009cited by this paper
• Therapeutic Effects of Human Mesenchymal Stem Cells on Traumatic Brain Injury in Rats: Secretion of Neurotrophic Factors and Inhibition of Apoptosis

  2009cited by this paper
• Frailty is associated with postoperative complications in older adults with medical problems.

  2009cited by this paper
• Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

  2009cited by this paper
• Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme

  2009cited by this paper
• Reproducible and persistent weakness in adult rats after surgical resection of motor cortex: evaluation with limb placement test

  2009cited by this paper
• Hemispheric Brain Injury and Behavioral Deficits Induced by Severe Neonatal Hypoxia-Ischemia in Rats Are Not Attenuated by Intravenous Administration of Human Umbilical Cord Blood Cells

  2009cited by this paper
• Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats.

  2009cited by this paper
• Erythropoietin as a neuroprotective agent in traumatic brain injury Review.

  2009cited by this paper
• Survival and proliferative roles of erythropoietin beyond the erythroid lineage

  2008cited by this paper
• Subacute neural stem cell therapy for traumatic brain injury.

  2008cited by this paper
• Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.

  2008cited by this paper
• The use of erythtropoietin in cerebral diseases.

  2008cited by this paper
• Patterns of care in elderly glioblastoma patients

  2008cited by this paper
• Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system.

  2008cited by this paper
• Epidemiology of brain tumors.

  2007cited by this paper
• One-Year Follow-Up After Bone Marrow Stromal Cell Treatment in Middle-Aged Female Rats With Stroke

  2007cited by this paper
• Cumulative index of health disorders as an indicator of aging-associated processes in the elderly: results from analyses of the National Long Term Care Survey.

  2007cited by this paper
• Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

  2007cited by this paper
• Erythropoietin Enhances Long-Term Neuroprotection and Neurogenesis in Neonatal Stroke

  2007cited by this paper
• Embryonic Stem Cell Transplantation after Experimental Traumatic Brain Injury Dramatically Improves Neurological Outcome, But May Cause Tumors

  2007cited by this paper
• Frailty in relation to the accumulation of deficits.

  2007cited by this paper
• The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats.

  2006cited by this paper
• Alterations in hippocampal neurogenesis following traumatic brain injury in mice.

  2006cited by this paper
• Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood

  2006cited by this paper
• Traumatic Brain Injury Rehabilitation: State of the Science

  2006cited by this paper
• Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats.

  2006cited by this paper
• A global clinical measure of fitness and frailty in elderly people

  2005cited by this paper
• Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain.

  2005cited by this paper
• Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

  2004cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Erythropoietin and the nervous system.

  2004cited by this paper
• Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury.

  2004cited by this paper
• Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.

  2004cited by this paper
• Transplantation of neural stem cells into the spinal cord after injury.

  2003cited by this paper
• [Transplantation of neural stem cells into spinal cord after injury].

  2003cited by this paper
• Debulking or biopsy of malignant glioma in elderly people – a randomised study

  2003cited by this paper
• Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project.

  2003cited by this paper
• Intravenous Administration of Human Umbilical Cord Blood Reduces Neurological Deficit in the Rat after Traumatic Brain Injury

  2002cited by this paper
• Central and peripheral nerve regeneration by transplantation of Schwann cells and transdifferentiated bone marrow stromal cells

  2002cited by this paper
• Increase of oligodendrocyte progenitor cells after spinal cord injury

  2001cited by this paper
• Erythropoietin acts as a trophic factor in neonatal rat intestine

  2001cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper
• Neuroprotection and Angiogenesis: Dual Role of Erythropoietin in Brain Ischemia.

  2000cited by this paper
• Short-course Radiotherapy in Elderly and Frail Patients with Glioblastoma Multiforme. A Phase II Study

  1999cited by this paper
• Complications and Expected Outcome of Glioma Surgery

  1999cited by this paper
• Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

  1999cited by this paper
• Clinical assessments as predictors of one year survival after hospitalization: implications for prognostic stratification.

  1988cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Stem Cell Therapy Approaches for Ischemia: Assessing Current Innovations and Future Directions

  2025cites this paper
• Research progress on pleiotropic neuroprotective drugs for traumatic brain injury

  2023cites this paper
• Stem Cell Therapy in Children with Traumatic Brain Injury

  2023cites this paper
• Fast-tracking regenerative medicine for traumatic brain injury

  2020cites this paper
• Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury

  2019cites this paper
• Potential application of an injectable hydrogel scaffold loaded with mesenchymal stem cells for treating traumatic brain injury.

  2018cites this paper
• Stem Cell Therapy for Traumatic Brain Injury: A Progress Update

  2018cites this paper
• The use of antioxidants in the treatment of traumatic brain injury

  2017cites this paper